WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2022)
Top pharmaceutical stocks in 2022 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
RDY
DR REDDYS LABORATORIES LTD
$8.30B1.55%37.70%$0.3870$0.7723%0
VTRS
VIATRIS INC
$10.34B5.51%73.00%$0.1200$0.4778%0
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.55BN/A0.00%N/AN/AN/AN/A
ACRX
ACELRX PHARMACEUTICALS INC
$30.50MN/A0.00%N/AN/AN/AN/A
PAHC
PHIBRO ANIMAL HEALTH CORP
$520.88M3.73%39.70%$0.1200$0.4862%02022-09-28
CTLT
CATALENT INC
$13.44BN/A0.00%N/AN/AN/AN/A
PCRX
PACIRA BIOSCIENCES INC
$2.41BN/A0.00%N/AN/AN/AN/A
SLDB
SOLID BIOSCIENCES INC
$56.95MN/A0.00%N/AN/AN/AN/A
ORGO
ORGANOGENESIS HOLDINGS INC
$410.99MN/A0.00%N/AN/AN/AN/A
ASRT
ASSERTIO HOLDINGS INC
$103.58MN/A0.00%N/AN/AN/AN/A
AMPH
AMPHASTAR PHARMACEUTICALS INC
$1.38BN/A0.00%N/AN/AN/AN/A
PRPH
PROPHASE LABS INC
$167.10M2.87%34.70%$0.3000$0.3049%0
OGI
ORGANIGRAM HOLDINGS INC
$274.49MN/A0.00%N/AN/AN/AN/A
AMYT
AMRYT PHARMA PLC
$436.40MN/A0.00%N/AN/AN/AN/A
ZTS
ZOETIS INC
$69.57B0.82%27.70%$0.3250$1.2310%0
CALT
CALLIDITAS THERAPEUTICS AB
$418.18MN/A0.00%N/AN/AN/AN/A
CRON
CRONOS GROUP INC
$1.07BN/A0.00%N/AN/AN/AN/A
ACB
AURORA CANNABIS INC
$345.42MN/A0.00%N/AN/AN/AN/A
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.16BN/A0.00%N/AN/AN/AN/A
SNDL
SNDL INC
$523.58MN/A0.00%N/AN/AN/AN/A
UPXI
UPEXI INC
$68.98MN/A0.00%N/AN/AN/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$8.69MN/A0.00%N/AN/AN/AN/A
BFRI
BIOFRONTERA INC
$21.20MN/A0.00%N/AN/AN/AN/A
DRRX
DURECT CORP
$128.69MN/A0.00%N/AN/AN/AN/A
TLRY
TILRAY BRANDS INC
$1.45BN/A0.00%N/AN/AN/AN/A
SBFM
SUNSHINE BIOPHARMA INC
$15.66MN/A0.00%N/AN/AN/AN/A
TKNO
ALPHA TEKNOVA INC
$103.65MN/A0.00%N/AN/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$360.01MN/A0.00%N/AN/AN/AN/A
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$40.04MN/A0.00%N/AN/AN/AN/A
OPTN
OPTINOSE INC
$286.47MN/A0.00%N/AN/AN/AN/A
PLXP
PLX PHARMA INC
$14.37MN/A0.00%N/AN/AN/AN/A
EOLS
EVOLUS INC
$452.68MN/A0.00%N/AN/AN/AN/A
ZYNE
ZYNERBA PHARMACEUTICALS INC
$37.52MN/A0.00%N/AN/AN/AN/A
HUGE
FSD PHARMA INC
$36.18MN/A0.00%N/AN/AN/AN/A
CGC
CANOPY GROWTH CORP
$1.32BN/A0.00%N/AN/AN/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$1.00BN/A0.00%N/AN/AN/AN/A
EVOK
EVOKE PHARMA INC
$6.49MN/A0.00%N/AN/AN/AN/A
SCYX
SCYNEXIS INC
$76.41MN/A0.00%N/AN/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$48.39MN/A0.00%N/AN/AN/AN/A
INCR
INTERCURE LTD
$192.50MN/A0.00%N/AN/AN/AN/A
ZOM
ZOMEDICA CORP
$209.71MN/A0.00%N/AN/AN/AN/A
VERU
VERU INC
$859.97MN/A0.00%$0.0700N/AN/A0
FLGC
FLORA GROWTH CORP
$61.17MN/A0.00%N/AN/AN/AN/A
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.74BN/A0.00%N/AN/AN/AN/A
PRFX
PAINREFORM LTD
$7.05MN/A0.00%N/AN/AN/AN/A
ANIP
ANI PHARMACEUTICALS INC
$544.38MN/A0.00%N/AN/AN/AN/A
JUPW
JUPITER WELLNESS INC
$14.89MN/A0.00%N/AN/AN/AN/A
SISI
SHINECO INC
$8.80MN/A0.00%N/AN/AN/AN/A
AGRX
AGILE THERAPEUTICS INC
$11.08MN/A0.00%N/AN/AN/AN/A
NLTX
NEOLEUKIN THERAPEUTICS INC
$28.87MN/A0.00%N/AN/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$14.60MN/A0.00%N/AN/AN/AN/A
BHC
BAUSCH HEALTH COMPANIES INC
$2.64BN/A0.00%N/AN/AN/AN/A
SNOA
SONOMA PHARMACEUTICALS INC
$6.51MN/A0.00%N/AN/AN/AN/A
AERI
AERIE PHARMACEUTICALS INC
$745.83MN/A0.00%N/AN/AN/AN/A
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
$10.95MN/A0.00%N/AN/AN/AN/A
HEXO
HEXO CORP
$65.37MN/A0.00%N/AN/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$68.13MN/A0.00%N/AN/AN/AN/A
ALVO
ALVOTECH
$1.53BN/A0.00%N/AN/AN/AN/A
CLVR
CLEVER LEAVES HOLDINGS INC
$26.50MN/A0.00%N/AN/AN/AN/A
HROW
HARROW HEALTH INC
$206.00MN/A0.00%N/AN/AN/AN/A
RDHL
REDHILL BIOPHARMA LTD
$28.73MN/A0.00%N/AN/AN/AN/A
IXHL
INCANNEX HEALTHCARE LTD
$116.31MN/A0.00%N/AN/AN/AN/A
PRGO
PERRIGO CO PLC
$5.07B2.71%-114.90%$0.2600$1.0246%0
ADMP
ADAMIS PHARMACEUTICALS CORP
$40.50MN/A0.00%N/AN/AN/AN/A
TAK
TAKEDA PHARMACEUTICAL CO LTD
$42.69BN/A0.00%$0.4064N/AN/A3
THTX
THERATECHNOLOGIES INC
$221.63MN/A0.00%N/AN/AN/AN/A
SCTL
SOCIETAL CDMO INC
$84.99MN/A0.00%N/AN/AN/AN/A
RLMD
RELMADA THERAPEUTICS INC
$955.32MN/A0.00%N/AN/AN/AN/A
KMDA
KAMADA LTD
$199.36MN/A0.00%N/AN/AN/AN/A
RMTI
ROCKWELL MEDICAL INC
$13.66MN/A0.00%N/AN/AN/AN/A
PETQ
PETIQ INC
$243.03MN/A0.00%N/AN/AN/AN/A
MDVL
MEDAVAIL HOLDINGS INC
$60.26MN/A0.00%N/AN/AN/AN/A
TXMD
THERAPEUTICSMD INC
$65.69MN/A0.00%N/AN/AN/AN/A
COLL
COLLEGIUM PHARMACEUTICAL INC
$549.43MN/A0.00%N/AN/AN/AN/A
VLNS
VALENS COMPANY INC
$53.73MN/A0.00%N/AN/AN/AN/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$37.68MN/A0.00%N/AN/AN/AN/A
SXTC
CHINA SXT PHARMACEUTICALS INC
$1.75MN/A0.00%N/AN/AN/AN/A
COSM
COSMOS HOLDINGS INC
$5.59MN/A0.00%N/AN/AN/AN/A
HAPP
HAPPINESS DEVELOPMENT GROUP LTD
$11.55MN/A0.00%$0.0150N/AN/A0
PTPI
PETROS PHARMACEUTICALS INC
$10.34MN/A0.00%N/AN/AN/AN/A
AVDL
AVADEL PHARMACEUTICALS PLC
$283.42MN/A0.00%N/AN/AN/AN/A
YCBD
CBDMD INC
$14.29MN/A0.00%N/AN/AN/AN/A
XXII
22ND CENTURY GROUP INC
$196.10MN/A0.00%N/AN/AN/AN/A
PROC
PROCAPS GROUP SA
$789.77MN/AN/AN/AN/AN/AN/A
AKAN
AKANDA CORP
$14.77MN/A0.00%N/AN/AN/AN/A
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$8.54BN/A0.00%$0.0720N/AN/A3
ELAN
ELANCO ANIMAL HEALTH INC
$6.00BN/A0.00%N/AN/AN/AN/A
ALIM
ALIMERA SCIENCES INC
$37.43MN/A0.00%N/AN/AN/AN/A
ATNX
ATHENEX INC
$31.50MN/A0.00%N/AN/AN/AN/A
LCI
LANNETT CO INC
$20.62MN/A0.00%N/AN/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$6.61MN/A0.00%N/AN/AN/AN/A
EMBC
EMBECTA CORP
$1.65B0.52%N/A$0.1500$0.155%0
TCDA
TRICIDA INC
$485.43MN/A0.00%N/AN/AN/AN/A
AMRX
AMNEAL PHARMACEUTICALS INC
$655.61MN/A0.00%N/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$196.58MN/AN/AN/AN/AN/AN/A
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$413.46MN/A0.00%N/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Sep 2022?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Dr Reddys Laboratories (NYSE:RDY)


Dr Reddys Laboratories (NYSE:RDY) is the top pharmaceutical stock with a Zen Score of 61, which is 31 points higher than the pharmaceutical industry average of 30. It passed 23 out of 38 due diligence checks and has strong fundamentals. Dr Reddys Laboratories has seen its stock lose -22.83% over the past year, overperforming other pharmaceutical stocks by 19 percentage points.

Dr Reddys Laboratories has an average 1 year price target of $69.00, an upside of 38.28% from Dr Reddys Laboratories's current stock price of $49.90.

Dr Reddys Laboratories stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Dr Reddys Laboratories, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the second best pharmaceutical stock with a Zen Score of 61, which is 31 points higher than the pharmaceutical industry average of 30. It passed 21 out of 38 due diligence checks and has strong fundamentals. Viatris has seen its stock lose -38.28% over the past year, overperforming other pharmaceutical stocks by 4 percentage points.

Viatris has an average 1 year price target of $11.80, an upside of 38.34% from Viatris's current stock price of $8.53.

Viatris stock has a consensus Sell recommendation according to Wall Street analysts. Of the 6 analysts covering Viatris, 0% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the third best pharmaceutical stock with a Zen Score of 58, which is 28 points higher than the pharmaceutical industry average of 30. It passed 18 out of 33 due diligence checks and has strong fundamentals. Ironwood Pharmaceuticals has seen its stock lose -24.83% over the past year, overperforming other pharmaceutical stocks by 17 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $14.33, an upside of 41.35% from Ironwood Pharmaceuticals's current stock price of $10.14.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Ironwood Pharmaceuticals, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 7 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) has an annual dividend yield of 5.51%, which is 3 percentage points higher than the pharmaceutical industry average of 2.53%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of 73% indicates that its high dividend yield is sustainable for the long-term.

2. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.73%, which is 1 percentage points higher than the pharmaceutical industry average of 2.53%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 39.7% indicates that its dividend yield is sustainable for the long-term.

3. Prophase Labs (NASDAQ:PRPH)


Prophase Labs (NASDAQ:PRPH) has an annual dividend yield of 2.87%, which is the same as the pharmaceutical industry average of 2.53%.

Prophase Labs's dividend payout ratio of 34.7% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -0.34% in the last day, and down -7.26% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 86, which is 55 points higher than the pharmaceutical industry average of 31. It passed 6 out of 7 valuation due diligence checks.

Viatris's stock has dropped -38.28% in the past year. It has overperformed other stocks in the pharmaceutical industry by 4 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Ironwood Pharmaceuticals has a valuation score of 86, which is 55 points higher than the pharmaceutical industry average of 31. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has dropped -24.83% in the past year. It has overperformed other stocks in the pharmaceutical industry by 17 percentage points.

3. Acelrx Pharmaceuticals (NASDAQ:ACRX)


Acelrx Pharmaceuticals (NASDAQ:ACRX) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Acelrx Pharmaceuticals has a valuation score of 71, which is 40 points higher than the pharmaceutical industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Acelrx Pharmaceuticals's stock has dropped -80.65% in the past year. It has underperformed other stocks in the pharmaceutical industry by -39 percentage points.

Are pharmaceutical stocks a good buy now?

43.75% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 87.73% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 20.09x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.